The anti-abortion movement's patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s recent approval of a second generic version of mifepristone, one of two drugs taken for a medication abortion.…
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Fallout persists from abortion pill approval The Food and Drug Administration is facing new pressure from lawmakers and anti-abortion groups, who are…
Sen. Bernie Sanders warned Vice President Harris to focus on working class issues over abortion, but Virginia's Spanberger continues targeting Earle-Sears on reproductive rights.
The White House on Friday defended the Food and Drug Administration’s (FDA) approval of a second generic version of the abortion drug mifepristone, but said it shouldn't be interpreted as an endorsement of the drug. The decision, made…
Sen. Bill Cassidy (R-La.) slammed the Food and Drug Administration's (FDA) approval of a new generic form of the abortion pill mifepristone on Thursday night, joining a chorus of other conservative critics. "I fully support President…
Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.
Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists.
EXCLUSIVE: Luke Brawley’s nonfiction agency Indox has boarded two new titles, Jaripeo by Efraín Mojica and Rebecca Zweig, and Scarlet Girls by Paula Cury. Both films are feature documentary debuts and are currently in post-production.…
WASHINGTON -- Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.
Recent events have led to fear and concern over dwindling abortion rights in the United States, especially when it comes to access to the abortion pill. Here's what's happening.